Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Targeting health subsidies through a nonprice mechanism: A randomized controlled trial in Kenya

Domaine:

healthcaresocioeconomic
Créateur:
PasVivMicAli
Éditeur:
Ame
Hôte:
Delivering chlorine to those who use it In developed countries, a consumer's valuation of a health product can be measured by his or her willingness to pay for it. But poorer individuals, especially those in developing countries, might want and need a product yet be unable to pay for it with money. Dupas et al. demonstrate that a nonprice voucher mechanism can be used to deliver chlorine for water treatment to people in Kenya who are too poor to pay for it, but who use it when they get it (see the Perspective by Olken). Having to redeem the vouchers screens out people who would accept the free chlorine solution but not use it. Science , this issue p. 889 ; see also p. 864

Visit

doi.org

Similaires

Targeting health subsidies through a non-price mechanism: A randomized controlled trial in KenyaPrice Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled TrialReplication data for: Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial

Targeting health subsidies through a non-price mechanism: A randomized controlled trial in Kenya

Free provision of preventive health products can dramatically increase access in low income countrie

Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial

Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one

Replication data for: Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial

Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one